Summary of John Abramson's Sickening
Everest Media,
Everest Media LLC
Libro electrónico
23
Páxinas
family_home
Apto
info
reportAs valoracións e as recensións non están verificadas Máis información
Acerca deste libro electrónico
Please note: This is a companion version & not the original book. Sample Book Insights: #1 The author was sent a heartbreaking note from a woman who had seen her on television discussing safety issues associated with Vioxx and Celebrex, two widely used pain relievers. She asked if she could review her daughter’s medical records. #2 As the Palmer family struggled with their loss, one of the world’s largest drug companies was dealing with a crisis of its own. On September 30, 2004, Merck pulled its blockbuster Vioxx off the market. #3 The two articles that defended Vioxx were published in the world’s most prestigious medical journal, the NEJM. But when I read the fine print, I was shocked to discover that both authors had financial ties to Merck. #4 I realized that the information in the NEJM could not be trusted. I searched for the data behind an article I’d read in the Washington Post, which reported that a JAMA article claiming to show that Celebrex caused fewer serious GI complications than older over-the-counter anti-inflammatory drugs was also based on a misrepresentation.
Valora este libro electrónico
Dános a túa opinión.
Información de lectura
Smartphones e tabletas
Instala a aplicación Google Play Libros para Android e iPad/iPhone. Sincronízase automaticamente coa túa conta e permíteche ler contido en liña ou sen conexión desde calquera lugar.
Portátiles e ordenadores de escritorio
Podes escoitar os audiolibros comprados en Google Play a través do navegador web do ordenador.
Lectores de libros electrónicos e outros dispositivos
Para ler contido en dispositivos de tinta electrónica, como os lectores de libros electrónicos Kobo, é necesario descargar un ficheiro e transferilo ao dispositivo. Sigue as instrucións detalladas do Centro de Axuda para transferir ficheiros a lectores electrónicos admitidos.
